Structure Of Key Breast Cancer Target Enzyme Unraveled
Wednesday, January 7, 2009 - 17:35
in Health & Medicine
Most people know that breast cancer is the most common cancer among women affecting about 1 in 8 women in the United States and the second leading cause of cancer death in women, after lung cancer. Seventy-five to 80 percent of all breast cancer tumors are estrogen-fed. A key estrogen-related breakthrough has been discovered by a scientist in Buffalo, NY which can be the basis for developing customized novel breast cancer drugs that cause minimal side effects.
Read the whole article on Science Daily
More from Science Daily
Related
- HWI scientist first in world to unravel structure of key breast cancer target enzymeWed, 7 Jan 2009, 13:43:41 EST
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- UB study explores how women make decisions about breast cancer surgeryMon, 26 Oct 2009, 16:18:59 EDT
- Low-dose estrogen shown safe and effective for metastatic breast cancerTue, 18 Aug 2009, 16:32:01 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT